This is the second annual conference for the American Society of Ketamine Physicians. A conference involving multi-disciplinary speakers discussing ketamine use for mood disorders, psychotherapy and pain conditions. Please join us for this educational conference and extraordinary networking experience.
This conference is sure to sell out so be sure to register soon!
AMERICAN SOCIETY OF KETAMINE PHYSICIANS
2nd ANNUAL MEETING
SEPTEMBER 20th and 21st
SEPTEMBER 19th – THURSDAY
6:30-8:30pm - ASKP Meet and Greet Event
SEPTEMBER 20th – FRIDAY
8:00am – 9:00am – Breakfast, coffee, registration
9:00am - 9:30am – Opening Speaker
9:30am – 10:25am – Sanjay Mathew, M.D.
“Ketamine for Treatment-Resistant depression: where does it fit?”
10:25am – 11:20am – Lori Calabrese, M.D.
Discussing response to suicidality with ketamine therapy
11:20am – 11:30am – Morning Break with snack
11:30am – 12:25pm – Gerard Sanacora, M.D., Ph.D.
“Lessons learned from phase 2 and 3 clinical trials with Esketamine”
12:25pm – 1:20pm – Amit Anand, M.D.
"Comparative Effectiveness of Ketamine for Treatment Resistant Depression"
1:20pm – 2:10 pm – Lunch
2:10pm – 3:05pm – Rachel Dalthorp, M.D.
“Hormone Disruption in Ketamine Treatment”
3:05pm – 4:00pm – Daniel Richman, M.D.
“IV Ketamine for CRPS (Complex Regional Pain Syndrome)”
4:00pm – 4:10pm – Afternoon Break
4:10pm – 5:10pm – Jessica Katzman, Psy.D.
“Rapid Depression Remission and the ‘Therapeutic Bends’ ”
SEPTEMBER 21st - SATURDAY
7:45 am – 8:30 am – Breakfast
8:30am-10:40am – Break Out Sessions
TOPICS Available During All Times:
Opening a Clinic
Billing for Services
10:40am – 10:50am – Morning Break
10:50am – 11:45am – Omid J. Naim, M.D.
“An Integrative approach to Psychedelic Therapy: Promoting Transformation and Community in the Healing Process”
11:45am – 12:40pm – David Sheehan, M.D.
“Suicidality: Assessment, Documentation and Pharmacological Treatment”
12:40pm – 1:30pm – Lunch
1:30pm – 2:25pm – Jeffrey Becker, M.D.
Discussing fMRI findings in ketamine treatment
2:25pm – 3:20pm – Jennifer Winegarden, D.O.
“Ketamine in Refractory Cancer Pain: Changing the Course of End-of-Life Treatment”
3:20pm – 3:30pm – Afternoon Break
3:30pm –5:00pm – Lightening Abstracts
Ketamine for Anxiety
Ketamine and PMDD
Combination Therapy Ketamine and TMS
Accreditation and Designation Statements 2019 ASKP Conference
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and American Society of Ketamine Physicians. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians. The PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 14 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.